NCT00261053View on ClinicalTrials.gov

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

September 30, 2005

Study Completion Date

December 31, 2005

Conditions
Genetic Disorders
Interventions
DRUG

i.v. recombinant human C1 inhibitor

Trial Locations (1)

2333 CN

For information contact Sonja Visscher, Leiden

Sponsors
All Listed Sponsors
lead

Pharming Technologies B.V.

INDUSTRY